Results
1 -
10 of
26Bradner et al..
Chemical Phylogenetics of Histone Deacetylases, Nature Chemical Biology, 2010 Guerini V, Barbui V, Spinelli O, Salvi A, Dellacasa C, Carobbio A, Introna M, Barbui T, Golay J, Rambaldi A.
The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F, Leukemia, 2007 Zhang Xin, Lv Peng-Cheng, Li Dong-Dong, Zhang Wei-Ming, Zhu Hai-Liang.
Navigating into the chemical space between MGCD0103 and SAHA: novel histone deacetylase inhibitors as a promising lead, Med. Chem. Commun., 2015 Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents, Journal of Hematology & Oncology Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells, Journal of Thrombosis and Thrombolysis The DAC system and associations with multiple myeloma, Investigational New Drugs New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer, Journal of Hematology & Oncology Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines, Targeted Oncology Conventional and Investigational Therapy for Primary Myelofibrosis, Myeloproliferative Neoplasms